Cyanogen bromide peptide from bovine cardiac myosin containing two essential thiols Evidence for sequence homology with skeletal myosin in the region of the active site  by Flink, Irwin L. et al.
Volume 84, number 2 FEBS LETTERS December 1977 
CYANOGEN BROMIDE PEPTIDE FROM BOVINE CARDIAC MYOSIN CONTAINING 
TWO ESSENTIAL  THIOLS 
Evidence for sequence homology with skeletal myosin in the region of  the active site 
Irwin L. FLINK and Eugene MORKIN 
Departments o f  Internal Medicine and Pharmacology, University o f  Arizona Health Sciences Center, Tucson, Arizona 85 724 
and 
Marshall ELZINGA 
Biology Department, Brookhaven National Laboratory, Upton, L.L, New York 11973, USA 
Received 3October 1977 
1. Introduction 
In cardiac and skeletal myosin, modification of one 
essential thiol group per myosin head, the so-called SH1 
thiol, produces an increase in Ca2÷-ATPase activity and 
a simultaneous loss of K*(EDTA)-ATPase activity 
[1,2]. From these data, together with changes in the 
rate of hydrolysis of ATP analogs after thiol modifica- 
tion, it has been concluded that the SHI thiol may be 
involved in the binding of nucleotide to the active site 
[2,3]. Furthermore, Seidel [4] and Mendelson et al. 
[5] have suggested on the basis of spin- and fluores- 
cence-labeling experiments hat the SHI thiol groups 
are at or near the actin binding site of myosin. 
A second thiol group, the so-called SH2 thiol, also 
has been implicated in the regulation of myosin ATPase 
activity [6]. Seidel [7] showed that selective modifica- 
tion of the SH2 thiols produces changes in ATPase 
activities and nucleotide specificity that are similar to 
those observed following modification of the SH1 
thiols. Burke et al. [8] have found that when MgATP 
is bound to myosin the two essential thiol groups, 
SIll and SH2, are brought into close spatial proximity 
since in this situation they can be cross-linked by the 
bifunctional reagent, N,N'-p-phenylenedimaleimide, 
which has a cross-linking span of 12-14 A. 
Very little information has been available about the 
primary structure of the myosin heavy chains in the 
region of the two essential thiol groups. Yamashita 
et al. [9] have summarized the studies on the peptides 
from skeletal myosin that contain SH1 and SH2 thiols 
and have concluded that the sequence around SH2 is 
Arg-Cys-Asn-Gly-Val-Leu and that the sequence 
around SHI is Glu-Gly- I le-Arg-I le-Cys-Arg. 
Recently, Elzinga and Collins [10] have reported the 
isolation of a cyanogen bromide peptide of 92 residues 
from skeletal myosin that contains the two essential 
thiols in exactly these sequences. Here we report he 
isolation of a cyanogen bromide fragment from bovine 
cardiac myosin that contains these two thiols in a 
sequence closely homologous to the skeletal myosin 
peptide. This structural similarity between skeletal 
and cardiac myosins in the region at or near the 
active site may explain many of the similarities in 
their enzymatic properties. 
2. Experiments and results 
Myosin was isolated from about 600 g bovine left 
ventricle by the method of Banerjee t al. [3]. The 
most rapidly reacting class of thiols in myosin, the 
so-called SHt thiols, were alkylated using iodo-[14C] - 
acetamide according to the method [11]. After 
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dialysis to remove the labeled alkylating reagent, he 
protein was denatured by addition of dry urea to a 
final concentration f 8 M. Dithioerythritol was added 
in 100-fold excess over the number of moles of 
cysteine in myosin. The mixture was stirred overnight 
under nitrogen and the unreacted thiols were blocked 
using non-radioactive iodoacetamide. Myosin prepara- 
tions contained about 1.2-1.4 mol [14C]carboxy- 
methyl cysteine/mol. Values obtained from amino 
acid analysis varied from 38-42  mol carboxymethyl 
cysteine/mol, indicating that the cysteinyls had reacted 
almost quantitatively. 
Figure 1 shows the electrophoretic pattern obtained 
with a cyanogen bromide digest of cardiac myosin in 
which the rapidly reacting thiols were [14C]carboxy- 
methylated. The major radioactive peak was associated 
with a band having an apparent molecular mass of 
about 8300. 
Fractionation by gel filtration of a cyanogen 
bromide digest of cardiac myosin in which the rapidly 
reacting thiols were labeled is shown in fig.2. The 
fractions indicated were pooled, lyophilized and 
applied to a column of SP-Sephadex in 8 M urea 
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Fig.2. Chromatography of a cyanogen bromide digest of 
bovine cardiac myosin in which the rapidly reacting thiols 
were [~4C]carboxymethylated. About 2.5 g protein digest 
was dissolved in 25% acetic acid. The solution was clarified 
by centrifugation at27 000 X g for 30 min. The supernatant 
solution containing about 90% of the radioactivity was placed 
on a 8.5 X 90 cm column of Sephadex G-75 in 25% acetic 
acid at 23°C and developed at a flow rate of 40 ml/h. About 
10 ml fractions were collected and analyzed for absorbance 
and radioactivity. Fractions in the major adioactive peak 
were pooled as indicated and lyophilized. 
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(fig.3). Fractions under the major radioactive peak 
were pooled and lyophilized. Removal of small 
amounts of contaminating on-radioactive p ptides 
was accomplished by passage over a 1 × 10 cm 
column of Dowex l-X8 which had been equilibrated 
with 8 M urea and 0.1 M Na2CO3-NaHCO3 buffer, 
pH 8.9. Under these conditions, the radiolabeled thiol 
Fig.1. SDS-urea polyacryiamlde g l electrophoresis of a 
cyanogen bromide digest of cardiac myosin in which the 
rapidly reacting thiols were [ 14C] carboxymethvlated. Ahnut 
100/zg protein containing about 1600 cpm a4C were appliea 
to 0.5 X 12 cm disk gels prepared as described [20], except 
that N,N'-diallyltartardiamide was substituted for N,N'- 
methylene bisacrylamide [ 21 ]. The cyanogen bromide 
fragments of myoglobin were run simultaneously as a guide 
to the approx, molecular mass of the peptides. Gels were 
stained with Coomassie brilliant blue and destained ina 
mixture of 7.5% acetic acid and 25% methanol. Destained gels 
were frozen in dry ice, sliced at 1 mm intervals and dissolved 
by incubation i 0.7 ml 2% periodic acid for 1 h at 37°C. 
About 10 ml Aquasol (New England Nuclear) were added to 
each vial and the radioactivity was measured by liquid scintilla. 
tion counting. 
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Fig.3. SP-Sephadex chromatography of the pooled major adioactive peak from the initial filtration on Sephadex G-75. About 
25 X 106 ~4C cpm were applied to a 1 × 60 cm column of SP-Sephadex previously equilibrated at55°C in 8 M urea and 0.01 M 
ammonium formate, pH 2.5. A linear 0.22-0.38 M NaCI gradient was applied and 4 ml fractions were collected at a flow rate of 
about 25 ml/h. Fractions were analyzed for absorbance and radioactivity and the major radioactive peak was pooled and 
ly ophilized. 
peptide was not retained on the column, suggesting 
that it carried an overall positive charge. 
The procedure described above resulted in recovery 
of the radiolabeled thiol peptide with a yield of 
about 62%. The peptide was homogenous in SDS-urea 
polyacrylamide g ls (fig.4) and co-electrophoresed 
with the major labeled peak in myosin digests. The 
apparent molecular mass of this peptide as determined 
from SDS-urea polyacrylamide gels and the amino 
acid composition (table 1) appeared to be similar to 
that of the SH1-SH2 thiol peptide recently isolated 
from skeletal myosin [10]. The skeletal myosin 
peptide also contains the unusual amino acid residue, 
Nr-methylhistidine, which is found in skeletal myosin, 
but not in cardiac myosin [12]. 
A partial sequence was determined by automated 
Edman degradation of the intact cardiac myosin 
peptide in a Beckman 890C sequencer. Identification 
of the PTH amino acids obtained from the sequencer 
was made by thin layer chromatography [ 13] and 
amino acid analysis following regeneration of the 
amino acids by hydroiodic acid hydrolysis [14]. In 
table 2 a partial sequence of the cardiac peptide is 
compared with that of a similar region of the skeletal 
myosin SH1-SH2 thiol peptide. The cardiac peptide 
is shown with Met next to the NH2-terminal His 
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Fig.4. SDS-urea polyacrylamide g l electrophoresis of the 
purified labeled thiol peptide. About 1900 14C cpm labeled 
peptide were applied to a 0.5 × 12 cm disk gel which was 
prepared and analyzed for radioactivity asdescribed in fig. 1. 
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Table 1 
Amino acid composition of SHa -SH 2 thiol-containing 
peptides from bovine cardiac myosin and 
rabbit skeletal myosin 
Cardiac peptide Skeletal peptide 
Cysteine 1.48 (2) 2 
Aspartic acid 9.14 (9) 6 a 
Threonine 2.13 (2) 2 
Serine 2.69 (3) 5 
Glutamic acid 13.40 (13) 11 b 
Proline 2.15 (2) 2 
Glycine 6.33 (6) 8 
Alanine 5.73 (6) 5 
Valine 2.81 (3) 5 
Isoleucine 4.75 (5) 6 
Leucine I1.14 (11) 12 
Tyrosine 1.77 (2) 3 
Phenylalanine 4.07 (4) 6 
Lysine 8.43 (8) 9 
Histidine 3.44 (3) 3 
N'r-Nethylhistidine - 1 
Arginine 6.14 (6) 5 
Homoserine 0.85 (1) 1 
86 92 
a Includes two residues asparagine 
b Includes four residues glutamine 
Each value on the cardiac peptide is the average of six 
determinations. The eysteine content was determined as
carboxymethyl c steine, The composition of the peptide 
from skeletal myosin has been published [10] 
because the adjacent peptide would have to end in 
Met in order for cyanogen bromide cleavage to occur. 
It is evident hat the first 28 residues of  the cardiac 
peptide correspond almost exactly to positions 7 -34  
of the skeletal peptide. The cardiac and skeletal 
peptides differ at only three positions and all of  the 
substitutions are conservative. 
Determination of  the radioactivity at each step 
during Edman degradation of  the cardiac peptide 
revealed that about 94% of the counts were associated 
with the carboxymethyl cysteinyl in step 15. This 
corresponds to the cysteinyl residue at position 21 
in the skeletal peptide (table 2), which was identified 
previously as the SH1 thiol [9]. About 6% of the 
counts were found at step 5 in association with the 
carboxymethyl cysteine residue which corresponds 
to the cysteinyl at position 11 in the sequence of the 
skeletal myosin peptide. This cysteinyl has been 
Table 2 
Comparison of the partial sequence of the SH x -SH 2 thiol 
peptide from bovine cardiac myosin with residues 1-34 of 
a similar peptide from rabbit skeletal myosin [10] 
1 2 3 4 5 6 l 8 
~ovine card iac  (Met) 
- His - Gin 
Rabbit ske le ta l  Glu - His - Glu - Leu - Va] - Leu 
9 I0  I I  12 13 14 15 16 17 18 19 20 21 
- Leu - Arg - Cys -Asn  - Gly - Val - Leu - Glu - Gly - l l e  - Arg - l l e  - Cys 
22 23 24 25 26 27 28 29 30 31 32 33 34 
Asn Gly 
- A rg  ~ Lys  - G ly  - Pbe  - P ro  - - A rg  - l l e  - keu  - Tyr  - - Asp  - Phe  
Set Ala 
previously identified as the SH~ thiol [9]. Thus the 
two essential thiols in both cardiac and skeletal myosin 
are separated by only 9 residues. Moreover, the striking 
differences in reactivity of the two thiol groups in 
cardiac myosin are consistent with earlier observations 
on the reactivity of these thiols in skeletal myosin 
[]5]. 
I f  the two thiol residues are at or near the nucleo- 
tide binding site, it seems likely that this region of the 
molecule would contain both a hydrophobic pocket 
for the nucleoside ring and one or more basic residues, 
probably Arg [16], that would electrostatically 
interact with the polyphosphate side chain. The Arg 
residues at positions 10, 19 and 22 (skeletal myosin 
peptide numbering) are all close to either SHI or SH2, 
providing possible binding sites. The amino acid 
residues at the NH2-terminus of the peptide (4-31 in 
the skeletal peptide and 9-31 in the cardiac peptide) 
include a high proportion of hydrophobic side chains 
that could form a hydrophobic pocket. 
Although the binding of  adenine nucleotides to 
cardiac myosin has not been studied extensively, 
Banerjee and Morkin [I 7] have found that about 
1.5 mol MgADP are bound/tool bovine cardiac 
myosin in 0.5 M KCI, 4°C, with an association con- 
stant of  1.8 × l0 s M -1 , which is similar to values 
reported recently for binding of MgADP to rabbit 
skeletal myosin [18,19]. These findings would be 
consistent with the strong preservation of sequence 
homology between possible nucleotide binding regions 
of these proteins noted in this report. 
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